0 XP   0   0   0

ASTRAZENECA PHARMA INDIA LTD.
Buy, Hold or Sell?

Should you buy, hold or sell ASTRAZENECA PHARMA INDIA LTD.?

I guess you are interested in ASTRAZENECA PHARMA INDIA LTD.. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

Let's analyse ASTRAZENECA PHARMA INDIA LTD.

Let's start. I'm going to help you getting a better view of ASTRAZENECA PHARMA INDIA LTD.. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

  1. Company's Financial Health
    A deep dive into the books. How are the numbers doing? Is ASTRAZENECA PHARMA INDIA LTD. even making a profit? Is the company skyrocketing? Or is it sinking like the Titanic. The trend is your friend.
  2. Market Valuation
    Finally, you now have an insight of how ASTRAZENECA PHARMA INDIA LTD. is doing in the market. If the company is worth buying. The latest step is to find out how other investors value ASTRAZENECA PHARMA INDIA LTD.. The closing price on 2023-02-03 was INR3,308 per share. Is the company over- or underpriced?
  3. Key Performance Indicators
    A total overlook on how the company is doing. Based on the (trends in) the key performance indicators.
ASTRAZENECA PHARMA INDIA LTD. Daily Candlestick Chart
ASTRAZENECA PHARMA INDIA LTD. Daily Candlestick Chart
Summary









1. Valuation of ASTRAZENECA PHARMA INDIA LTD.




Current price per share

INR3,308.35

2. Growth of ASTRAZENECA PHARMA INDIA LTD.




Is ASTRAZENECA PHARMA INDIA LTD. growing?

Current yearPrevious yearGrowGrow %
How rich?$62.3m$55.6m$6.7m10.8%

How much money is ASTRAZENECA PHARMA INDIA LTD. making?

Current yearPrevious yearGrowGrow %
Making money$7.5m$11.3m-$3.8m-51.5%
Net Profit Margin7.6%11.5%--

How much money comes from the company's main activities?

3. Financial Health of ASTRAZENECA PHARMA INDIA LTD.




Comparing to competitors in the industry




  Industry Rankings ()  



Summary

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a profit.
Using its assets, the company is efficient in making profit.
Using its investors money, the company is less efficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

1.1. Profitability of ASTRAZENECA PHARMA INDIA LTD..

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit ASTRAZENECA PHARMA INDIA LTD. earns for each ₹1 of revenue.

  • Above 10% is considered healthy but always compare ASTRAZENECA PHARMA INDIA LTD. to the  industry mean.
  • A Net Profit Margin of 7.6% means that ₹0.08 for each ₹1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of ASTRAZENECA PHARMA INDIA LTD.:

  • The MRQ is 7.6%. The company is making a profit. +1
  • The TTM is 7.6%. The company is making a profit. +1
Trends
Current periodCompared to+/- 
MRQ7.6%TTM7.6%0.0%
TTM7.6%YOY11.5%-3.8%
TTM7.6%5Y8.0%-0.3%
5Y8.0%10Y7.2%+0.7%
1.1.2. Return on Assets

Shows how efficient ASTRAZENECA PHARMA INDIA LTD. is using its assets to generate profit.

  • Above 5% is considered healthy but always compare ASTRAZENECA PHARMA INDIA LTD. to the  industry mean.
  • 7.2% Return on Assets means that ASTRAZENECA PHARMA INDIA LTD. generated ₹0.07 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of ASTRAZENECA PHARMA INDIA LTD.:

  • The MRQ is 7.2%. Using its assets, the company is efficient in making profit. +1
  • The TTM is 7.2%. Using its assets, the company is efficient in making profit. +1
Trends
Current periodCompared to+/- 
MRQ7.2%TTM7.2%0.0%
TTM7.2%YOY12.0%-4.9%
TTM7.2%5Y9.0%-1.8%
5Y9.0%10Y8.3%+0.7%
1.1.3. Return on Equity

Shows how efficient ASTRAZENECA PHARMA INDIA LTD. is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare ASTRAZENECA PHARMA INDIA LTD. to the  industry mean.
  • 12.0% Return on Equity means ASTRAZENECA PHARMA INDIA LTD. generated ₹0.12 for each ₹1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of ASTRAZENECA PHARMA INDIA LTD.:

  • The MRQ is 12.0%. Using its investors money, the company is less efficient in making profit.
  • The TTM is 12.0%. Using its investors money, the company is less efficient in making profit.
Trends
Current periodCompared to+/- 
MRQ12.0%TTM12.0%0.0%
TTM12.0%YOY20.5%-8.4%
TTM12.0%5Y16.2%-4.1%
5Y16.2%10Y15.0%+1.2%

1.2. Operating Efficiency of ASTRAZENECA PHARMA INDIA LTD..

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient ASTRAZENECA PHARMA INDIA LTD. is operating .

  • Measures how much profit ASTRAZENECA PHARMA INDIA LTD. makes for each ₹1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare ASTRAZENECA PHARMA INDIA LTD. to the  industry mean.
  • An Operating Margin of 0.0% means the company generated ₹0.00  for each ₹1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of ASTRAZENECA PHARMA INDIA LTD.:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-0.0%
TTM-5Y5.2%-5.2%
5Y5.2%10Y5.3%-0.1%
1.2.2. Operating Ratio

Measures how efficient ASTRAZENECA PHARMA INDIA LTD. is keeping operating costs low.

  • Below 1 is considered healthy (always compare to  industry mean).
  • An Operation Ratio of 1.37 means that the operating costs are ₹1.37 for each ₹1 in net sales.

Let's take a look of the Operating Ratio trends of ASTRAZENECA PHARMA INDIA LTD.:

  • The MRQ is 1.367. The company is inefficient in keeping operating costs low. -1
  • The TTM is 1.367. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ1.367TTM1.3670.000
TTM1.367YOY1.266+0.101
TTM1.3675Y1.127+0.241
5Y1.12710Y1.004+0.123

1.3. Liquidity of ASTRAZENECA PHARMA INDIA LTD..

1.3. Liquidity
1.3.1. Current Ratio

Measures if ASTRAZENECA PHARMA INDIA LTD. is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to  industry mean).
  • A Current Ratio of 2.12 means the company has ₹2.12 in assets for each ₹1 in short-term debts.

Let's take a look of the Current Ratio trends of ASTRAZENECA PHARMA INDIA LTD.:

  • The MRQ is 2.121. The company is able to pay all its short-term debts. +1
  • The TTM is 2.121. The company is able to pay all its short-term debts. +1
Trends
Current periodCompared to+/- 
MRQ2.121TTM2.1210.000
TTM2.121YOY2.039+0.083
TTM2.1215Y1.786+0.335
5Y1.78610Y1.709+0.077
1.3.2. Quick Ratio

Measures if ASTRAZENECA PHARMA INDIA LTD. is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare ASTRAZENECA PHARMA INDIA LTD. to the  industry mean.
  • A Quick Ratio of 1.61 means the company can pay off ₹1.61 for each ₹1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of ASTRAZENECA PHARMA INDIA LTD.:

  • The MRQ is 1.607. The company is very able to pay all its short-term debts with the most liquid assets. +2
  • The TTM is 1.607. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ1.607TTM1.6070.000
TTM1.607YOY1.460+0.147
TTM1.6075Y1.320+0.287
5Y1.32010Y1.255+0.065

1.4. Solvency of ASTRAZENECA PHARMA INDIA LTD..

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of ASTRAZENECA PHARMA INDIA LTD. assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare ASTRAZENECA PHARMA INDIA LTD. to industry mean.
  • A Debt to Asset Ratio of 0.40 means that ASTRAZENECA PHARMA INDIA LTD. assets are financed with 40.3% credit (debt) and the remaining percentage (100% - 40.3%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of ASTRAZENECA PHARMA INDIA LTD.:

  • The MRQ is 0.403. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.403. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.403TTM0.4030.000
TTM0.403YOY0.411-0.008
TTM0.4035Y0.445-0.042
5Y0.44510Y0.448-0.003
1.4.2. Debt to Equity Ratio

Measures if ASTRAZENECA PHARMA INDIA LTD. is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare ASTRAZENECA PHARMA INDIA LTD. to the  industry mean.
  • A Debt to Equity ratio of 67.5% means that company has ₹0.67 debt for each ₹1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of ASTRAZENECA PHARMA INDIA LTD.:

  • The MRQ is 0.675. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.675. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.675TTM0.6750.000
TTM0.675YOY0.698-0.023
TTM0.6755Y0.809-0.134
5Y0.80910Y0.818-0.009

2. Market Valuation of ASTRAZENECA PHARMA INDIA LTD.

2. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every ₹1 in earnings ASTRAZENECA PHARMA INDIA LTD. generates.

  • Above 15 is considered overpriced but always compare ASTRAZENECA PHARMA INDIA LTD. to the  industry mean.
  • A PE ratio of 125.83 means the investor is paying ₹125.83 for every ₹1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of ASTRAZENECA PHARMA INDIA LTD.:

  • The EOD is 134.267. Seems overpriced? -1
  • The MRQ is 125.826. Seems overpriced? -1
  • The TTM is 125.826. Seems overpriced? -1
Trends
Current periodCompared to+/- 
EOD134.267MRQ125.826+8.442
MRQ125.826TTM125.8260.000
TTM125.826YOY123.833+1.993
TTM125.8265Y103.905+21.921
5Y103.90510Y105.811-1.906
2.2. Price Earnings to Growth Ratio

Measures the predicted future growth of ASTRAZENECA PHARMA INDIA LTD..

  • Lower is better.
  • A PEG ratio of 1 means the market price of the stock and the expected future earnings are on par.

Let's take a look of the Price Earnings to Growth Ratio trends of ASTRAZENECA PHARMA INDIA LTD.:

  • The MRQ is 190.577. Seems overpriced? -1
  • The TTM is 190.577. Seems overpriced? -1
Trends
Current periodCompared to+/- 
MRQ190.577TTM190.5770.000
TTM190.577YOY95.841+94.736
TTM190.5775Y94.718+95.859
5Y94.71810Y94.7180.000

2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of ASTRAZENECA PHARMA INDIA LTD. is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to industry mean).
  • A PB ratio of 15.16 means the investor is paying ₹15.16 for each ₹1 in book value.

Let's take a look of the Price to Book Ratio trends of ASTRAZENECA PHARMA INDIA LTD.:

  • The EOD is 16.173. Seems overpriced? -1
  • The MRQ is 15.156. Seems overpriced? -1
  • The TTM is 15.156. Seems overpriced? -1
Trends
Current periodCompared to+/- 
EOD16.173MRQ15.156+1.017
MRQ15.156TTM15.1560.000
TTM15.156YOY25.327-10.171
TTM15.1565Y16.468-1.311
5Y16.46810Y15.452+1.015
2. Total Gains per Share

3. Summary

3.1. Key Performance Indicators

The key performance indicators of ASTRAZENECA PHARMA INDIA LTD. compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share--22.08822.0880%36.692-40%23.082-4%34.093-35%
Book Value Growth--1.1211.1210%1.252-10%1.182-5%1.182-5%
Book Value Per Share--204.556204.5560%182.468+12%150.378+36%140.173+46%
Book Value Per Share Growth--1.1211.1210%1.252-10%1.182-5%1.182-5%
Current Ratio--2.1212.1210%2.039+4%1.786+19%1.709+24%
Debt To Asset Ratio--0.4030.4030%0.411-2%0.445-10%0.448-10%
Debt To Equity Ratio--0.6750.6750%0.698-3%0.809-17%0.818-17%
Dividend Per Share--2.0002.0000%2.0000%1.400+43%1.333+50%
Dividend Per Share Growth--1.0001.0000%2.000-50%1.200-17%1.200-17%
Eps--24.64024.6400%37.320-34%24.598+0%21.835+13%
Eps Growth--0.6600.6600%1.292-49%1.334-51%1.334-51%
Free Cash Flow Per Share--36.47236.4720%38.828-6%24.020+52%22.180+64%
Free Cash Flow Per Share Growth--0.9390.9390%1.326-29%3.764-75%3.764-75%
Free Cash Flow To Equity Per Share--32.68832.6880%35.240-7%21.019+56%19.255+70%
Free Cash Flow To Equity Per Share Growth--0.9280.9280%1.318-30%2.821-67%2.821-67%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%
Intrinsic Value_10Y_max--798.143--------
Intrinsic Value_10Y_min--669.913--------
Intrinsic Value_1Y_max--45.955--------
Intrinsic Value_1Y_min--44.654--------
Intrinsic Value_3Y_max--164.007--------
Intrinsic Value_3Y_min--154.430--------
Intrinsic Value_5Y_max--313.322--------
Intrinsic Value_5Y_min--285.570--------
Net Profit Margin--0.0760.0760%0.115-33%0.080-4%0.072+6%
Operating Margin----0%-0%0.052-100%0.053-100%
Operating Ratio--1.3671.3670%1.266+8%1.127+21%1.004+36%
Pb Ratio16.173+6%15.15615.1560%25.327-40%16.468-8%15.452-2%
Pe Ratio134.267+6%125.826125.8260%123.833+2%103.905+21%105.811+19%
Peg Ratio--190.577190.5770%95.841+99%94.718+101%94.718+101%
Price Per Share3308.350+6%3100.3503100.3500%4621.450-33%2592.320+20%2314.442+34%
Price To Total Gains Ratio137.344+6%128.709128.7090%119.442+8%104.266+23%88.599+45%
Profit Growth--0.6600.6600%1.292-49%1.334-51%1.334-51%
Quick Ratio--1.6071.6070%1.460+10%1.320+22%1.255+28%
Return On Assets--0.0720.0720%0.120-40%0.090-20%0.083-13%
Return On Equity--0.1200.1200%0.205-41%0.162-26%0.150-20%
Revenue Growth--0.9900.9900%0.978+1%1.085-9%1.085-9%
Total Gains Per Share--24.08824.0880%38.692-38%24.482-2%35.426-32%
Total Gains Per Share Growth--0.6230.6230%1.463-57%1.100-43%1.100-43%
Usd Book Value--62389580.00062389580.0000%55652740.000+12%45865412.000+36%42752866.667+46%
Usd Book Value Change Per Share--0.2690.2690%0.448-40%0.282-4%0.416-35%
Usd Book Value Per Share--2.4962.4960%2.226+12%1.835+36%1.710+46%
Usd Dividend Per Share--0.0240.0240%0.0240%0.017+43%0.016+50%
Usd Eps--0.3010.3010%0.455-34%0.300+0%0.266+13%
Usd Free Cash Flow--11123960.00011123960.0000%11842540.000-6%7264856.000+53%6054046.667+84%
Usd Free Cash Flow Per Share--0.4450.4450%0.474-6%0.293+52%0.271+64%
Usd Free Cash Flow To Equity Per Share--0.3990.3990%0.430-7%0.256+56%0.235+70%
Usd Price Per Share40.362+6%37.82437.8240%56.382-33%31.626+20%28.236+34%
Usd Profit--7515200.0007515200.0000%11382600.000-34%7502268.000+0%6659573.333+13%
Usd Revenue--98283200.00098283200.0000%99254320.000-1%91530500.000+7%87431503.333+12%
Usd Total Gains Per Share--0.2940.2940%0.472-38%0.299-2%0.432-32%
 EOD+2 -3MRQTTM+0 -0YOY+11 -285Y+21 -2110Y+22 -20

3.2. Fundamental Score

Let's check the fundamental score of ASTRAZENECA PHARMA INDIA LTD. based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15134.267
Price to Book Ratio (EOD)Between0-116.173
Net Profit Margin (MRQ)Greater than00.076
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than11.607
Current Ratio (MRQ)Greater than12.121
Debt to Asset Ratio (MRQ)Less than10.403
Debt to Equity Ratio (MRQ)Less than10.675
Return on Equity (MRQ)Greater than0.150.120
Return on Assets (MRQ)Greater than0.050.072
Total6/10 (60.0%)

3.3. Technical Score

Let's check the technical score of ASTRAZENECA PHARMA INDIA LTD. based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5039.310
Ma 20Greater thanMa 503,401.740
Ma 50Greater thanMa 1003,371.780
Ma 100Greater thanMa 2003,295.965
OpenGreater thanClose3,369.800
Total4/5 (80.0%)



Latest Balance Sheet

Balance Sheet of 2021-12-31. Currency in INR. All numbers in thousands.

Summary
Total Assets8,565,600
Total Liabilities3,451,700
Total Stockholder Equity5,113,900
 As reported
Total Liabilities 3,451,700
Total Stockholder Equity+ 5,113,900
Total Assets = 8,565,600

Assets

Total Assets8,565,600
Total Current Assets7,056,700
Long-term Assets7,056,700
Total Current Assets
Cash And Cash Equivalents 88,200
Short-term Investments 900
Net Receivables 858,900
Inventory 1,413,200
Other Current Assets 400
Total Current Assets  (as reported)7,056,700
Total Current Assets  (calculated)2,361,600
+/- 4,695,100
Long-term Assets
Property Plant Equipment 766,900
Other Assets 163,000
Long-term Assets  (as reported)1,508,900
Long-term Assets  (calculated)929,900
+/- 579,000

Liabilities & Shareholders' Equity

Total Current Liabilities3,326,500
Long-term Liabilities125,200
Total Stockholder Equity5,113,900
Total Current Liabilities
Accounts payable 1,880,600
Other Current Liabilities 154,600
Total Current Liabilities  (as reported)3,326,500
Total Current Liabilities  (calculated)2,035,200
+/- 1,291,300
Long-term Liabilities
Long term Debt Total 50,200
Capital Lease Obligations Min Short Term Debt86,300
Long-term Liabilities  (as reported)125,200
Long-term Liabilities  (calculated)136,500
+/- 11,300
Total Stockholder Equity
Common Stock50,000
Retained Earnings 5,044,400
Total Stockholder Equity (as reported)5,113,900
Total Stockholder Equity (calculated)5,094,400
+/- 19,500
Other
Capital Stock50,000
Cash And Equivalents4,396,000
Cash and Short Term Investments 4,485,100
Common Stock Shares Outstanding 25,000
Liabilities and Stockholders Equity 8,565,600
Net Invested Capital 5,113,900
Net Working Capital 3,730,200



Balance Sheet

Currency in INR. All numbers in thousands.

 Trend2021-12-312020-12-312019-12-312018-12-312017-12-312016-12-31
> Total Assets 
4,154,900
4,605,400
5,618,000
7,063,600
7,747,100
8,565,600
8,565,6007,747,1007,063,6005,618,0004,605,4004,154,900
   > Total Current Assets 
2,515,500
3,209,200
4,047,200
5,423,200
6,187,600
7,056,700
7,056,7006,187,6005,423,2004,047,2003,209,2002,515,500
       Cash And Cash Equivalents 
1,132,300
1,094,500
1,683,600
818,000
30,100
88,200
88,20030,100818,0001,683,6001,094,5001,132,300
       Short-term Investments 
6,100
116,800
0
1,690,000
56,560
900
90056,5601,690,0000116,8006,100
       Net Receivables 
609,500
594,100
861,200
955,800
851,900
858,900
858,900851,900955,800861,200594,100609,500
       Inventory 
577,100
1,131,500
1,181,000
1,651,500
1,601,800
1,413,200
1,413,2001,601,8001,651,5001,181,0001,131,500577,100
       Other Current Assets 
109,200
157,500
198,800
208,100
100
400
400100208,100198,800157,500109,200
   > Long-term Assets 
0
0
1,570,800
1,640,400
1,559,500
1,508,900
1,508,9001,559,5001,640,4001,570,80000
       Property Plant Equipment 
916,500
790,300
817,300
957,700
849,800
766,900
766,900849,800957,700817,300790,300916,500
       Long-term Assets Other 
0
0
6,000
-1,158,400
20,135
29,903
29,90320,135-1,158,4006,00000
> Total Liabilities 
1,926,200
2,136,100
2,610,000
3,419,200
3,185,400
3,451,700
3,451,7003,185,4003,419,2002,610,0002,136,1001,926,200
   > Total Current Liabilities 
1,903,400
2,069,500
2,589,800
3,272,400
3,035,000
3,326,500
3,326,5003,035,0003,272,4002,589,8002,069,5001,903,400
       Accounts payable 
876,600
1,272,000
1,682,000
2,097,200
1,783,700
1,880,600
1,880,6001,783,7002,097,2001,682,0001,272,000876,600
       Other Current Liabilities 
300,900
229,500
219,200
196,200
136,500
154,600
154,600136,500196,200219,200229,500300,900
   > Long-term Liabilities 
0
0
20,200
146,800
150,400
125,200
125,200150,400146,80020,20000
       Long term Debt Total 
0
0
0
93,000
86,300
50,200
50,20086,30093,000000
       Capital Lease Obligations Min Short Term Debt
0
0
0
118,400
121,400
86,300
86,300121,400118,400000
> Total Stockholder Equity
2,228,700
2,469,300
3,008,000
3,644,400
4,561,700
5,113,900
5,113,9004,561,7003,644,4003,008,0002,469,3002,228,700
   Common Stock
50,000
50,000
50,000
50,000
50,000
50,000
50,00050,00050,00050,00050,00050,000
   Retained Earnings 
1,438,700
1,675,000
2,213,500
2,855,000
4,495,800
5,044,400
5,044,4004,495,8002,855,0002,213,5001,675,0001,438,700
   Capital Surplus 000000
   Treasury Stock000000
   Other Stockholders Equity 
740,000
744,300
744,500
739,400
0
0
00739,400744,500744,300740,000



Balance Sheet

Currency in INR. All numbers in thousands.




Cash Flow

Currency in INR. All numbers in thousands.




Income Statement

Currency in INR. All numbers in thousands.


Latest Income Statement (annual, 2021-12-31)

Gross Profit (+$)
totalRevenue8,056,000
Cost of Revenue-3,655,600
Gross Profit4,400,4004,400,400
 
Operating Income (+$)
Gross Profit4,400,400
Operating Expense-7,359,500
Operating Income693,600-2,959,100
 
Operating Expense (+$)
Research Development-
Selling General Administrative3,436,400
Selling And Marketing Expenses-
Operating Expense7,359,5003,436,400
 
Net Interest Income (+$)
Interest Income104,000
Interest Expense-9,500
Net Interest Income105,30094,500
 
Pretax Income (+$)
Operating Income693,600
Net Interest Income105,300
Other Non-Operating Income Expenses-
Income Before Tax (EBT)830,400693,600
EBIT - interestExpense = -9,500
616,000
625,500
Interest Expense9,500
Earnings Before Interest and Taxes (ebit)-839,900
Earnings Before Interest and Taxes (ebitda)1,009,400
 
After tax Income (+$)
Income Before Tax830,400
Tax Provision-214,400
Net Income From Continuing Ops616,000616,000
Net Income616,000
Net Income Applicable To Common Shares616,000
 
Non-recurring Events
Discontinued Operations-
Extraordinary Items-
Effect of Accounting Charges-
Other Items-
Non Recurring-
Other Operating Expenses-
Total Other Income/Expenses Net--105,300
 

Comments

Join the conversation.

Leave a comment

Stay informed with my latest content.

Subscribe to my newsletter and receive an email as soon as I add content to PenkeTrading.com.


By clicking Register, you agree to the General Terms and Conditions.
Penke's Market Notifications
ENLT.TA
2 hours ago

I found you a STOCH Bearish Reversal Divergence on the daily chart of ENLT.TA.

ENLT.TA Daily Candlestick Chart
GBPEUR.FOREX
5 hours ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of GBPEUR.FOREX.

GBPEUR.FOREX Daily Candlestick Chart
NZDPHP.FOREX
5 hours ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of NZDPHP.FOREX.

NZDPHP.FOREX Daily Candlestick Chart
NZDIDR.FOREX
5 hours ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of NZDIDR.FOREX.

NZDIDR.FOREX Daily Candlestick Chart
MYRGBP.FOREX
5 hours ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of MYRGBP.FOREX.

MYRGBP.FOREX Daily Candlestick Chart
GBPMYR.FOREX
5 hours ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of GBPMYR.FOREX.

GBPMYR.FOREX Daily Candlestick Chart
GBPIDR.FOREX
5 hours ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of GBPIDR.FOREX.

GBPIDR.FOREX Daily Candlestick Chart
SGDGBP.FOREX
5 hours ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of SGDGBP.FOREX.

SGDGBP.FOREX Daily Candlestick Chart
GBPSGD.FOREX
5 hours ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of GBPSGD.FOREX.

GBPSGD.FOREX Daily Candlestick Chart
CADNOK.FOREX
5 hours ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of CADNOK.FOREX.

CADNOK.FOREX Daily Candlestick Chart
SVRT.TA
5 hours ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of SVRT.TA.

SVRT.TA Daily Candlestick Chart
PHTM.TA
5 hours ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of PHTM.TA.

PHTM.TA Daily Candlestick Chart
NICE.TA
5 hours ago

I found you a Golden Cross on the daily chart of NICE.TA.

NICE.TA Daily Candlestick Chart
NFTA.TA
5 hours ago

I found you a MACD Bearish Hidden Divergence on the daily chart of NFTA.TA.

NFTA.TA Daily Candlestick Chart
ICB.TA
6 hours ago

I found you a STOCH Bullish Hidden Divergence on the daily chart of ICB.TA.

ICB.TA Daily Candlestick Chart
FRSX.TA
6 hours ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of FRSX.TA.

FRSX.TA Daily Candlestick Chart
DCMA.TA
6 hours ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of DCMA.TA.

DCMA.TA Daily Candlestick Chart
ARD.TA
6 hours ago

I found you a Death Cross on the daily chart of ARD.TA.

ARD.TA Daily Candlestick Chart
MCRNT.TA
7 hours ago

I found you a STOCH Bearish Reversal Divergence on the daily chart of MCRNT.TA.

MCRNT.TA Daily Candlestick Chart